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The genome of Bacillus subtilis contains two genes that code for membrane proteins that belong to the
2-hydroxycarboxylate transporter family. Here we report the functional characterization of one of the two, yxkJ,
which codes for a transporter protein named CimHbs. The gene was cloned and expressed in Escherichia coli
and complemented the citrate-negative phenotype of wild-type E. coli and the malate-negative phenotype of the
E. coli strain JRG4008, which is defective in malate uptake. Subsequent uptake studies in whole cells express-
ing CimHbs clearly demonstrated the citrate and malate transport activity of the protein. Immunoblot analysis
showed that CimHbs is a 48-kDa protein that is well expressed in E. coli. Studies with right-side-out membrane
vesicles demonstrated that CimHbs is an electroneutral proton-solute symporter. No indications were found
for the involvement of Na ions in the transport process. Inhibition of the uptake catalyzed by CimHbs by
divalent metal ions, together with the lack of effect on transport by the chelator EDTA, showed that CimHbs
translocates the free citrate and malate anions. Among a large set of substrates tested, only malate, citra-
malate, and citrate competitively inhibited citrate transport catalyzed by CimHbs. The transporter is strictly
stereoselective, recognizing only the S enantiomers of malate and citramalate. Remarkably, though citramalate
binds to the transporter, it is not translocated.
Di- and tricarboxylate uptake in the gram-positive bacterium
Bacillus subtilis has not been studied extensively. The scarce
reports stem from the 1970s and early 1980s. Two uptake
systems have been described for C4-dicarboxylates. Willecke
and Lange (37) reported a malate uptake system that was
induced by malate and responsible for growth on malate min-
imal medium. The second system was less specific and was
claimed to transport malate, succinate, and fumarate. It was
described in cells grown in yeast extract (15) and in the pres-
ence of citrate (14) or was claimed to be expressed constitu-
tively (9). The last study showed, by studies with membrane
vesicles, that the transporter was of the secondary type. Simi-
larly, it was demonstrated that the uptake of the tricarboxylate
citrate in B. subtilis was catalyzed by a secondary transporter
(8). Remarkably, uptake of citrate was dependent on the avail-
ability of divalent metal ions (8, 27).
The publication of the complete genome sequence of B.
subtilis (20) provoked the molecular characterization of di- and
tricarboxylate transport in the organism. A screen using dele-
tion strains identified an operon containing two open reading
frames (ydbE and ydbH) that was responsible for growth on
fumarate and succinate but not malate (1). The gene product
YdbH is a homologue of the dicarboxylate transporters (Dct)
found in gram-negative bacteria. In the same screen, no trans-
porter for malate was identified. A malate transporter was
identified by heterologous expression of the yufR gene of B.
subtilis in Escherichia coli (36). The gene product, termed
MaeNbs, catalyzed Na-coupled malate transport, but neither
the physiological function nor the expression was studied in B.
subtilis. MaeNbs is a member of the 2-hydroxycarboxylate
transporter (2HCT) family, which contains secondary trans-
porters for citrate and/or malate (see below). In the same
study, a second malate transporter with a more complicated
mode of action was described. YqkI catalyzes antiport of H-
malate against Na-lactate. It was proposed that the trans-
porter plays a role in malate uptake and Na-H exchange
under low-oxygen or low proton motive force (PMF) condi-
tions (36).
For citrate, the situation is at least as complicated. Two
secondary transporters, CitMbs and CitHbs, have been studied
in some detail. They were characterized upon expression in E.
coli (10) and shown to transport citrate in complex with diva-
lent metal ions, but with complementary specificity for the
metal ions (19). CitMbs transports citrate in complex with
Mg2, Mn2, Ni2, Co2, and Zn2, while CitHbs transports
citrate in complex with Ca2, Sr2, and Ba2. CitMbs is the
transporter responsible for growth of B. subtilis on minimal
medium containing citrate as a sole carbon source. Its expres-
sion is subject to carbon catabolite repression (35, 38). The
physiological function of CitHbs is unknown. It was also dem-
onstrated that B. subtilis takes up the free citrate anion; how-
ever, neither CitMbs nor CitHbs accounted for this activity
(19). CitMbs and CitHbs are in a novel family of secondary
transporters that contains a third gene from B. subtilis, yraO, of
unknown function.
The 2HCT family mentioned above contains another poten-
tial transporter for carboxylate uptake in B. subtilis coded by
the open reading frame yxkJ. This transporter, termed here
CimHbs (for citrate, malate, H symporter of B. subtilis), is the
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subject of the present study. The 2HCT family contains trans-
porters for malate and citrate, some of which have been stud-
ied extensively. The family contains Na and H symporters
(CitSkp of Klebsiella pneumoniae, MaeNbs of B. subtilis, and
MaePsb of Streptococcus bovis [17, 24, 34, 36]) but also citrate-
lactate and malate-lactate exchangers found in lactic acid bac-
teria (CitPlcm of Leuconostoc mesenteroides and MlePll of
Lactococcus lactis [2, 25]). The last two transporters are in-
volved in secondary metabolic energy generation (23, 26, 28).
Substrate specificity studies revealed that the symporters in the
family are very specific, transporting only citrate or malate,
while the exchangers catalyze a wide range of 2-hydroxycar-
boxylates (2). Here we show that CimHbs of B. subtilis is a
proton symporter that transports both citrate and malate.
MATERIALS AND METHODS
Strains and growth conditions. The bacterial strains used in this study are
listed in Table 1. E. coli strains were routinely grown in flasks in Luria-Bertani
broth (LB) at 37°C under continuous shaking at 150 rpm. When appropriate,
carbenicillin and spectinomycin were added at final concentrations of 50 g/ml.
Expression of CimHbs from the plasmid pETCimH (see below) was induced by
adding 100 M isopropylthiogalactopyranoside (IPTG) when the optical density
of the culture measured at 660 nm was 0.6. The cells were harvested by centrif-
ugation 1 h after induction.
Complementation of the Mal phenotype of E. coli strain JRG4008 was
assayed on a minimal malate broth (11) supplemented with 0.1% LB. The
medium was inocculated with a single colony of JRG4008 carrying pET302 or
pETCimH from an LB plate and incubated for 14 h at 37°C with vigorous
shaking.
Cloning of CimHbs. The yxkJ gene was amplified from chromosomal DNA
isolated from B. subtilis 168 by PCR. The forward primer (5-GGGAGGTTTT
TCCATGGGAGAGC-3) was centered around the beginning of the gene and
contained an NcoI site (italicized) around the ATG start codon. The reverse
primer (5-CGTTTGACGAAGATCTAGATTGCGGGGATCA-3) was cen-
tered around the end of the gene and contained an XbaI site (italicized) just
downstream of the stop codon. The PCR product was digested with NcoI and
XbaI and ligated into the vector pET302, a pTRC99 derivative (32) that was
digested with the same two restriction enzymes. The resulting plasmid,
pETCimH, codes for CimHbs extended with six histidines (His tag) at the N
terminus. Expression is under the control of the IPTG-inducible lac promoter.
The nucleotide sequence of the insert was checked by sequencing (Biomedical
Technology Centre, Groningen, The Netherlands); no unexpected mutations had
occurred.
Immunoblot analysis. Crude membranes were prepared by sonication of the
cells followed by removal of debris by centrifugation for 5 min in an Eppendorf
tabletop centrifuge operated at 6,000 rpm. Subsequently, the supernatant was
centrifuged for 5 min at 14,000 rpm in an Eppendorf tabletop centrifuge to
collect the membranes. The protein concentrations in the samples were deter-
mined with the DC protein assay kit (Bio-Rad Laboratories, Richmond, Calif.).
Samples containing 10 g of total membrane protein were loaded onto a sodium
dodecyl sulfate–12.5% polyacrylamide gel. After sodium dodecyl sulfate-polyac-
rylamide gel electrophoresis, the proteins were transferred to polyvinylidene
difluoride membranes (Boehringer Mannheim) by semidry electroblotting. The
blots were analyzed using monoclonal antibodies directed against a six-His tag
(Dianova, Hamburg, Germany). The antibodies were visualized using the West-
ern-light chemiluminescence detection kit (Tropix, Bedford, Mass.).
Preparation of RSO membrane vesicles. Right-side-out (RSO) membrane
vesicles were prepared by the osmotic lysis procedure as described previously
(16). Membrane vesicles resuspended in 50 mM potassium phosphate (KPi)
buffer( pH 6.1) were rapidly frozen in liquid nitrogen and stored at 80°C.
Protein concentrations were determined with the DC protein assay kit.
Uptake in whole cells. Citrate and malate uptake in whole cells was measured
by rapid filtration as described previously (21). Briefly, cells were harvested by
centrifugation and washed once with ice-cold 50 mM KPi (pH 6.1), after which
they were resuspended to an optical density measured at 660 nm of 10. The cells
were diluted 10-fold in 50 mM KPi (pH 6.1), and 100-l samples were incubated
for 8 min at 30°C with magnetic stirring. At time zero, [1,5-14C]citrate (114
mCi/mmol) or L-[1,4(2,3)-14C]malate (25 mCi/mmol) was added to yield final
concentrations of 4.4 and 19.6 M, respectively. Uptake was stopped by the
addition of 2 ml of ice-cold 0.1 M LiCl solution immediately followed by filtering
through a 0.45-m-pore-size nitrocellulose filter. The filter was washed once with
2 ml of ice-cold 0.1 M LiCl, after which the filters were submerged in scintillation
fluid and the retained radioactivity was counted in a liquid scintillation counter.
The background was estimated by adding the radiolabeled substrate to the cell
suspension after the addition of 2 ml of ice-cold LiCl, immediately followed by
filtering.
Uptake in RSO membranes. Uptake in RSO vesicles was essentially per-
formed like uptake in whole cells with the following differences. Before the
addition of the radiolabeled substrates, the membranes (final protein concen-
tration, 0.5 mg/ml) in 50 mM KPi (pH 6.1) were incubated for 2 min at 30°C with
200 M phenazine methosulfate (PMS) and 10 mM potassium ascorbate under
a flow of water-saturated air with magnetic stirring. To determine the influence
of Na on citrate transport, membranes containing CimHbs of B. subtilis or
CitSkp of K. pneumoniae were washed four times in a special low-Na KPi buffer
(pH 6.1; Merck, Darmstadt, Germany) and resuspended to 0.5 mg of membrane
protein/ml in the same buffer. Initial rates of uptake were determined in dupli-
cate from the uptake during the first 10 s. The reported kinetic parameters are
the averages of two or three independent measurements.
Homologous and heterologous exchange. RSO membrane vesicles were al-
lowed to accumulate radiolabeled [1,5-14C]citrate driven by the electron donor
system ascorbate-PMS for 1 min as described above. The PMF was dissipated by
the addition of the uncoupler carbonylcyanide p-trifluormethoxy-phenylhydra-
zone (FCCP; 10 M). When indicated, at the same time, citrate, L-malate, or
L-citramalate was added to a final concentration of 1 mM. The release of label
from the membranes was followed during 1 min by rapid filtration at various time
points.
Transport driven by artificial gradients. Artificial ion gradients across RSO
membranes were imposed essentially as described previously (31). Briefly, RSO
vesicles were resuspended to a final protein concentration of 5 mg/ml in a buffer
containing 25 mM KPi (pH 6.1), 100 mM K-acetate, and 100 M valinomycin. A
PMF consisting of a pH gradient (pH) and a membrane potential () was
generated by rapid 100-fold dilution of the concentrated membranes in a buffer
containing 25 mM sodium phosphate (NaPi) (pH 6.1) and 100 mM NaCl. To
generate a pH alone, valinomycin was omitted from the membrane suspension,
and to generate a  alone, NaCl in the dilution buffer was replaced with
Na-acetate. The dilution buffer contained 4.5 M radiolabeled [1,5-14C]citrate,
and the internal labeled substrate was measured after 10 and 15 s by rapid
filtration as described above.
RESULTS
The product of the open reading frame yxkJ on the genome
of B. subtilis, termed CimHbs, belongs to the 2HCT family.
Members of the 2HCT family transport citrate and/or malate
(see the introduction).
TABLE 1. Strains used in this study
Strain Relevant genotype Source or reference
B. subtilis 168 trpC2
E. coli DH5 (argF-lac)U169 (80DlacZM15) recA Life Technologies, Inc.
E. coli BL21(DE3) hsdS gal (clts857 ind 1 sam7 nin5 lacUV5-T7 gene 1) Novagen
E. coli TOP10 (80DlacZM15) lacX74 recA Invitrogen
E. coli SF100 F lacX74 galE galK thi rpsL (strA) phoA(PvuII) ompT 7
E. coli JRG4008 AN387 dctA::spc 12
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E. coli does not grow on citrate under aerobic conditions
because it lacks an uptake system for citrate (18). E. coli strain
DH5 was transformed with pETCimH, harboring the yxkJ
gene of B. subtilis under the control of the trc promoter, and
plated on Simmons citrate agar. The cells grew as large colo-
nies surrounded by blue halos, indicative of citrate metabolism.
DH5, or DH5 transformed with the vector alone, showed
poor growth (not shown), strongly suggesting that the insert
was responsible for the Cit phenotype.
E. coli strain JRG4008 is defective in dctA, a gene coding for
a malate transporter, and is unable to grow on malate as the
sole carbon source under aerobic conditions (12). When
JRG4008 was grown in Christensen indicator broth containing
malate (11), the color of the culture changed only slightly,
while growth of the wild-type E. coli strain DH5 in the same
medium shifted the color to purple. The low residual malate
metabolism in JRG4008 is probably due to low-level expres-
sion of one of the other malate transport systems (13).
JRG4008 expressing the yxkJ gene product CimHbs showed
the same color change that was observed with the wild-type
DH5 strain, indicating an improved malate uptake capacity
(not shown).
The complementation of E. coli DH5 for growth on citrate
and of strain JRG4008 for growth on malate suggests that
CimHbs, the product of the B. subtilis yxkJ gene, transports
both citrate and malate.
Transport activity and expression of CimHbs. Citrate and
malate transport activity in E. coli catalyzed by CimHbs was
measured in whole cells using radiolabeled substrates. The lack
of citrate uptake in wild-type E. coli is well documented in the
literature (10, 18, 19, 33). E. coli DH5 carrying the empty
plasmid pET302 did not transport [1,5-14C]citrate, while
DH5 expressing CimHbs showed a low but significant uptake
(Fig. 1A). A number of other E. coli strains, including
JRG4008, BL21(DE3), SF100, and TOP10 transformed with
the pETCimH plasmid, were also tested for citrate uptake with
much better results (Fig. 1A). The expression levels of CimHbs
in the cells were analyzed by Western blotting using an anti-
body directed against the N-terminal His tag (Fig. 1C). A clear
band running with an apparent molecular mass of 48 kDa was
observed in cells expressing CimHbs. In line with the observed
uptake activities, expression was very low in DH5.
A low level of L-[1,4(2,3)-14C]malate accumulation was ob-
served in the dctA-deficient strain JRG4008, which was in
agreement with the low level of malate metabolism on Chris-
tensen medium observed for this strain (Fig. 1B). Expression
of CimHbs in JRG4008 resulted in a rate of uptake of
L-[1,4(2,3)-14C]malate that was four to five times faster. The
initial rate of uptake of malate in the same batch of JRG4008
cells expressing CimHbs was about twice the initial rate of
uptake of citrate (compare Fig. 1A and B). Kinetic analysis of
malate transport in whole cells is hampered by the residual
uptake activity in the JRG4008 strain and by the increasing
PMF across the cell membrane in the presence of L-malate, as
evidenced by the stimulation of L-[U-14C]proline uptake in the
presence of L-malate (not shown). Therefore, the kinetics of
citrate and malate transport catalyzed by CimHbs was analyzed
in RSO membrane vesicles (see below).
Mode of energy coupling. RSO membrane vesicles were
prepared from E. coli TOP10 cells expressing CimHbs. Upon
the generation of a PMF by the artificial electron donor system
ascorbate-PMS, the vesicles took up citrate at an initial rate of
3 nmol/min  mg. In the absence of the electron donor system,
or in the presence of the uncoupler FCCP, no uptake was
observed (Fig. 2A). Similar results were obtained for malate
transport in RSO membrane vesicles prepared from the
malate-negative strain JRG4008 expressing CimHbs, which
took up malate at a rate of 1.2 nmol/min  mg in the presence
of ascorbate-PMS (Fig. 2B). Importantly, in contrast to what
was observed in whole cells (Fig. 1B), no background malate
FIG. 1. Citrate and malate uptake in whole cells expressing CimHbs. (A) Uptake of [1,5-14C]citrate was measured in whole cells of E. coli strain
JRG4008 carrying the empty plasmid pET302 (F) and strains JRG4008 (), DH5 (E), BL21(DE3) (), TOP10 (), and SF100 (ƒ) expressing
CimHbs. (B) Malate transport activity was measured in whole cells of E. coli JRG4008 carrying the empty pET302 vector (F) or expressing CimHbs
(). (C) Expression levels of CimHbs in the cells used for the uptake experiments shown in panel A. The immunoblot of membrane extracts of
strains JRG4008 carrying plasmid pET302 (lane 1) and JRG4008 (lane 2), DH5 (lane 3), BL21(DE3) (lane 4), TOP10 (lane 5), and SF100 (lane
6) expressing CimHbs were analyzed using antibodies directed against the N-terminal His tag. Molecular mass markers are indicted on the right.
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uptake activity was observed in membrane vesicles prepared
from the host cells. Probably, binding-protein-dependent sys-
tems are involved in the background activity. It was consis-
tently observed that in membrane vesicles the rate of malate
transport was lower than the rate of citrate transport, in con-
trast to the results in whole cells. We have no explanation for
this phenomenon.
The PMF consists of a pH and the . The contribution of
pH and  to the driving force on citrate transport catalyzed
by CimHbs was investigated by applying artificial gradients
(31). Dilution of membrane vesicles equilibrated with 100 mM
potassium acetate 100-fold in a buffer without potassium ace-
tate and in the presence of the potassium ionophore valino-
mycin results in a PMF consisting of both pH and  gen-
erated by the diffusion of K ions and undissociated acetic acid
across the membrane. The result was a rapid uptake of citrate
into the lumen of the vesicles (Fig. 3). When the membranes
were diluted in the absence of valinomycin, where only a pH
develops, uptake of citrate was even higher. In contrast, dilu-
tion in a buffer containing 100 mM sodium acetate, where only
a  is imposed across the membrane, does not result in
detectable uptake of citrate. The experiments suggest that
CimHbs is an electroneutral proton symporter. The number of
protons transported is equal to the valence of the transported
anions.
Cation specificity of CimHbs. The 2HCT family of second-
ary transporters contains transporters that use H as well as
Na as the coupling ion. For instance, citrate transport by
CitSkp of K. pneumoniae is strictly coupled to transport of Na
(21, 33), while the exchangers CitPlcm and MlePll from lactic
acid bacteria cotransport protons. Vesicles of E. coli TOP10
expressing CimHbs were prepared in low-Na potassium phos-
phate buffer. Uptake of citrate by the vesicles with and without
added NaCl revealed no influence of Na (Fig. 4A), indicating
that sodium ions are not required for activity. In a control
experiment, E. coli vesicles containing CitSkp of K. pneu-
moniae resuspended in the same buffer showed citrate uptake
only in the presence of NaCl (Fig. 4B).
The effect of divalent metal ions on citrate transport by
CimHbs was tested in membrane vesicles. Ca2 and Mg2
were added at 10 mM concentration, which resulted in clear
inhibition of citrate transport (Fig. 4C). The presence of 1 mM
FIG. 2. Citrate and malate uptake catalyzed by CimHbs in RSO membranes. [1,5-14C]citrate uptake was measured in RSO vesicles prepared
from E. coli TOP10 expressing CimHbs (A), and L-[1,4(2,3)-14C]malate uptake was measured in RSO vesicles prepared from E. coli JRG4008
expressing CimHbs (B). The membranes were either not energized (E) or energized with Asc-PMS to generate a PMF (ƒ), or the PMF was
dissipated with 10 M FCCP ().
FIG. 3. Citrate uptake driven by artificial gradients. Artificial gra-
dients were imposed across RSO membranes prepared from E. coli
TOP10 expressing CimHbs as described in Materials and Methods.
[1,5-14C]citrate uptake was measured at pH 6.0 in the presence of both
the pH and  components (E), only pH (ƒ), and only  ().
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Ni2 resulted in almost complete abolition of citrate uptake.
The different degrees of inhibition are caused by differences in
complexation efficiency of the Ca2, Mg2, and Ni2 ions (19).
The addition of the chelator EDTA (1 mM) had no significant
effect on citrate uptake (Fig. 4C), indicating that the free
citrate anion is the preferred substrate for CimHbs.
Substrate specificity. A range of carboxylates was tested for
the ability to competitively inhibit citrate transport catalyzed
by CimHbs in RSO membranes. At 1 mM concentrations,
propionate, succinate, fumarate, and tricarbalate showed no
inhibition. A similar result was observed for the 2-oxo-carboxy-
lates, -ketoglutarate and pyruvate. Of the 2-hydroxy-carboxy-
lates, lactate, glycolate, citramalate, malate, and citrate, only
citramalate caused significant inhibition, in addition to citrate
and malate (not shown).
The exchangers CitPlcm and MlePll in the 2HCT family are
strictly stereoselective for the S enantiomers of dicarboxylates
(4). A 1 mM concentration of the S enantiomers of malate and
citramalate inhibited citrate uptake by CimH by 60 and 90%,
respectively (Fig. 5). The R enantiomers did not result in sig-
nificant inhibition even at a five-times-higher concentration,
indicating that CimHbs is also stereoselective.
The inhibition assay does not discriminate between a sub-
strate that is transported and a substrate that only binds to the
transporter. The ability of CimHbs to transport L-citramalate
was determined by heterologous exchange (2). RSO mem-
branes containing CimHbs were allowed to accumulate [1,5-
14C]citrate for 1 min driven by the artificial electron donor
system ascorbate-PMS (Fig. 2). Addition of the uncoupler
FCCP (time zero [Fig. 6]) resulted in a slow release of the label
from the membranes during the first minute. Addition of 1 mM
citrate or S-malate together with FCCP resulted in a much
faster release of label, indicative of homologous citrate-citrate
and heterologous citrate–S-malate exchange catalyzed by
CimHbs, respectively. However, addition of S-citramalate at a
concentration of 1 mM, which resulted in 90% inhibition of
PMF-dependent citrate uptake (Fig. 5), together with the un-
coupler FCCP did not increase the rate of release of label.
FIG. 4. Cation dependency of the activity of CimHbs. (A and B) Effect of an Na ion gradient on the citrate transport activity of CimHbs and
CitSkp of K. pneumoniae. RSO membranes prepared from E. coli expressing CimHbs (A) and CitSkp (B) were washed four times in low-Na KPi
buffer. [1,5-14C]citrate transport was measured in the absence (E) and presence of 1 (ƒ) and 10 () mM NaCl. (C) Effect of divalent cations on
citrate transport by CimHbs. [1,5-14C]citrate transport was measured in RSO vesicles prepared from E. coli TOP10 containing CimHbs in the
absence (‚) or presence () of 1 mM EDTA and in the presence of 10 mM MgCl2 (E), 10 mM CaCl2 (ƒ), and 1 mM NiCl2 ().
FIG. 5. Competitive inhibition of citrate transport in RSO vesicles.
Initial rates of [1,5-14C]citrate uptake were determined in the presence
of 1 mM concentrations of the competing substrates. The bars repre-
sent the initial rates of uptake in the absence and presence of com-
peting substrates. Shown are the averages and standard deviations
(error bars) of the results of two independent experiments.
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Apparently, S-citramalate binds to CimHbs, but is not or is
very poorly translocated.
Kinetic parameters. The kinetic parameters of CimHbs
were determined in RSO membrane vesicles in 50 mM KPi
(pH 6.1) and at 30°C. The data are summarized in Table 2.
CimHbs catalyzes citrate transport with a Km of 10 M and a
maximal rate of transport of 37 nmol/min  mg of protein.
Because of the lower transport rates for malate, it was difficult
to measure the Km for malate accurately. Rather, the affinity of
CimHbs for S-malate was inferred from the inhibition of ci-
trate uptake by unlabeled S-malate. The affinity for S-malate
was 2 orders of magnitude lower than that observed for citrate
(Ki 	 1.5 mM). On the other hand, the maximal rate of trans-
port was fourfold higher (167 nmol/min  mg). The affinity of
CimHbs for S-citramalate was likewise determined from the
inhibition of citrate uptake and was between the affinities for
citrate and S-malate (Ki 	 100 M).
DISCUSSION
The molecular basis of di- and tricarboxylate uptake in B.
subtilis is poorly understood. Three genes involved in C4-dicar-
boxylate transport have been identified. A mutant strain de-
fective in the ydbH gene showed a clear growth defect on the
dicarboxylates fumarate and succinate but not malate, suggest-
ing that the gene product is involved in the uptake of these
substrates (1). YdbH is a member of the glutamate transporter
family that contains a cluster of C4-dicarboxylate transporter
proteins (30). The YdbH protein was not further character-
ized. yufR of B. subtilis was expressed in E. coli and shown to be
a sodium-dependent malate transporter (36). The gene prod-
uct, termed MaeNbs, is a member of the 2HCT family, which
contains both citrate and malate transporters (2). The third
gene, yqkI, codes for a transporter that combines Na-H
antiporter activity and malate-lactate antiporter activity (36).
The transporter is homologous to other Na-H antiporters in
the NhaC family (29). The roles of the last two gene products
in the physiology of B. subtilis are unclear. Two genes products,
CitMbs and CitHbs, have been shown to be involved in the
uptake of the tricarboxylate citrate in complex with divalent
metal ions.
In this study, we characterized another transporter involved
in carboxylate uptake in B. subtilis. CimHbs, the product of the
yxkJ gene, is a member of the 2HCT family. CimHbs is a
PMF-driven secondary transporter for citrate and malate.
Transport catalyzed by CimHbs appears to be electroneutral,
i.e., driven by the pH across the membrane. Furthermore, the
Na ion motive force is not involved, and citrate is transported
in its free ionic form. The apparent affinity of CimHbs for
citrate is 2 orders of magnitude higher than for malate (10 M
and 1.5 mM, respectively). On the other hand, the maximal
rate of transport was fourfold higher for L-malate than for
citrate (167 and 37 nmol/min  mg protein, respectively).
Therefore, CimHbs is a high-affinity, low-capacity citrate trans-
porter and a low-affinity, high-capacity L-malate transporter
that could be involved in the uptake of both substrates under
physiological conditions.
In the 2HCT family, two groups of transporters can be dis-
criminated, with distinct physiological functions. One group
consists of the “classical” secondary transporters involved in
the uptake of substrates, a process that consumes metabolic
energy. The second group consists of exchangers that are in-
volved in the generation of metabolic energy by a secondary
mechanism (22). The transporters in the latter group, CitPlcm
and MlePll, catalyze the uptake of a divalent anion, citrate and
malate, respectively, coupled to the excretion of monovalent
lactate, which is a metabolic end product in lactic acid bacteria.
Electrogenic exchange of the divalent precursor and the mono-
valent product in combination with scalar proton consumption
in the cytoplasmic conversion of precursor into product result
in the generation of a PMF (22). The exchangers have three
characteristics that distinguish them from the other transport-
ers in the family: (i) exchange is catalyzed much faster than
unidirectional transport (4), (ii) an inverse membrane poten-
tial drives unidirectional transport (26), and (iii) a wide range
of 2-hydroxycarboxylates is transported (2). The characteristics
of CimHbs classify the transporter as a “traditional” one func-
tioning in the uptake of citrate and/or malate. CimHbs cata-
FIG. 6. Homologous and heterologous exchange catalyzed by
CimHbs. RSO membranes prepared from E. coli TOP10 expressing
CimHbs were energized with Asc-PMS and allowed to accumulate
[1,5-14C]citrate for 1 min. At time zero, 10 M FCCP was added alone
(E) or together with 1 mM concentrations of citrate (ƒ), L-malate ({),
and L-citramalate (). Indicated is the fraction of label retained in the
membranes relative to that at the zero time point.
TABLE 2. Kinetic parameters of CimHbs for uptake activity
in RSO membrane vesicles
Substrate Km (M) Kia (M)
Vmax
d
(nmol/min  mg of protein)
Citrate 12 





 100 167 
 20c
a Inhibition constant for the inhibition of citrate uptake.
b No significant turnover was observed.
c Calculated using the inhibitor constant and the rate of uptake of L-malate at
19.8 M.
d Vmax, maximal rate of transport.
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lyzes exchange faster than efflux (Fig. 6), but the rate is still
much lower than that observed for CitPlcm and MlePll. At-
tempts to drive citrate uptake catalyzed by an SCN diffusion
potential failed (not shown). Finally, though CimHbs trans-
ports both citrate and malate, it fails to translocate one of the
monocarboxylic 2-hydroxycarboxylates, such as lactate, which
is essential for precursor-product exchange.
The 2HCT family contains transporters with very strict sub-
strate specificities (e.g., CitSkp) as well as transporters with
very broad substrate specificities (the exchangers). Substrate
specificity and mutational studies have resulted in a model for
the binding site of the transporter in the latter group (3, 5, 6).
In the model, two interactions between protein and substrate
are essential for binding: one with the hydroxyl and one with
the carboxylate group of the 2-hydroxycarboxylate motif
present in all substrates. A third interaction with a “second”
carboxylate group is responsible for high-affinity binding of di-
and tricarboxylates and determines the preference of the trans-
porter for the S enantiomers of the substrates. The residue
involved in this interaction in CitPlcm is Arg425. Mutation of
this residue to Cys resulted in a dramatic loss of affinity for
S-malate, while the affinity for the monocarboxylate 2-hydroxy-
isobutyrate increased somewhat (6). As observed for the ex-
changers, CimHbs translocates only 2-hydroxycarboxylates, in-
dicating that interactions with the hydroxyl and the carboxyl
group are essential. CimHbs is strictly stereospecific and inter-
acts only with the S enantiomers of malate and citramalate.
The Arg residue responsible for the interaction in CitPlcm is
conserved in the family and corresponds to Arg432 in CimHbs.
The data suggest, as may be expected for homologous proteins,
that the global structure of the binding site in CitPlcm and
CimHbs is the same. Nevertheless, there are important differ-
ences. In CitPlcm, the interaction of the Arg residue with the
second carboxylate is not essential, while it is in CimHbs.
CimHbs does not accept substrates that lack the second car-
boxylate, i.e., monocarboxylates and the R enantiomers of di-
carboxylates. In the future, we plan to study this modulation of
substrate specificity within one family of transporters by mu-
tational studies.
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